Emergo by UL: Can RAMS Cut Through MedTech’s Regulatory Noise?

Emergo by UL provides regulatory intelligence through its Regulatory Affairs Management Suite (RAMS), a cloud-based platform that brings together medical-device market information, change monitoring, and registration tracking. It addresses the fragmented research and administrative work involved in evaluating new markets and maintaining product information across countries. By combining reference material with structured digital workflows, RAMS connects information gathering with operational planning.

The platform uses country-, device-, and classification-specific reports, process charts, and FAQs to organise its knowledge base. Regulatory Watch filters updates by selected markets, while guided questionnaires and Smart Builders support classification assessments and document preparation through predefined questions, templates, and step-by-step instructions. These are documented information-management and automation capabilities; the product page does not establish the use of machine learning or generative AI.

For day-to-day operations, RAMS reduces the need to assemble information from disconnected sources and manually sort registration records. Its tracker organises records by country, device, and status, supporting deadline visibility and internal information sharing. The practical benefits are less repetitive administrative work and a more consistent basis for market planning; the cited documentation does not quantify time savings or demonstrate improvements in clinical outcomes.

Last checked on October 17, 2026: Emergo by UL continues to offer RAMS for medical-device regulatory intelligence and registration management, with no dated product change in the past 12 months verified from the reviewed public sources.

What is Emergo by UL?

Emergo by UL provides regulatory intelligence through its Regulatory Affairs Management Suite (RAMS), a SaaS platform supporting medical-device and IVD market-entry planning, regulatory-change monitoring, and registration tracking. Designed for MedTech companies and regulatory affairs and quality assurance teams, RAMS combines country-specific reports and process charts with guided classification questionnaires and templated document preparation, drawing on Emergo by UL’s regulatory expertise. Its published documentation describes structured guidance and workflow automation but does not specify machine-learning or generative-AI functionality.

Intended Use and Limitations

• Emergo Global Consulting holds ISO 13485:2016 certificate FS 594789 for specified regulatory, clinical, quality-system, training, and in-country representation services; this is not a RAMS-specific software certification.

• Emergo explicitly limits its ISO 13485 certification to the Medical Market Access services and offices listed on the certificate, excluding its Human Factors Research and Design services.

• Emergo maintains a strategic alliance with Greenlight Guru for medical-device electronic quality management support; this does not establish native integration with RAMS.

• UL acquired Emergo in April 2017, establishing the corporate relationship behind the current Emergo by UL business.

• Emergo reported that more than 17,000 companies relied on RAMS in July 2023; this is a historical, vendor-reported adoption figure rather than a current independently verified customer count.

• Emergo’s privacy notice describes international data-transfer safeguards, including EU standard contractual clauses, but does not constitute independent certification of GDPR compliance.

• RAMS support documentation states that its databases and file systems are secured through Microsoft Azure; the cited security article dates to December 2019 and does not establish current security assurance.

• RAMS-specific ISO 27001 certification, SOC 2 attestation, HIPAA assurances, FDA clearance, and CE marking were not established in the reviewed public product and security materials.

• RAMS documentation describes regulatory intelligence and workflow automation but does not establish machine-learning or generative-AI functionality, so AI-specific validation claims remain unverified.